Fpr-rs7 belongs to the formyl peptide receptor (FPR) family, a cluster of G-protein coupled receptors (GPCRs) involved in immune regulation and sensory functions.
| Feature | Details | Source |
|---|---|---|
| Gene Name | Fpr-rs7 | |
| UniProt ID | Q71MR7 | |
| Chromosomal Location | Mouse chromosome 17A3.2 | |
| Family Members | Fpr1, Fpr-rs1, Fpr-rs2, Fpr-rs3, Fpr-rs4, Fpr-rs6, Fpr-rs7 |
Mouse FPR receptors exhibit greater diversity than human counterparts, complicating functional extrapolation . For example:
Fpr1: Binds N-formylated peptides (e.g., fMLF), mediating neutrophil chemotaxis .
Fpr-rs1/2: Bind anti-inflammatory lipoxins (e.g., LxA4) and resolvins .
Fpr-rs7: No confirmed ligands; potential roles include olfactory sensing or pathogen detection, as suggested by its homology to sensory receptors .
Fpr-rs7 is primarily used in:
| Application | Method | Source |
|---|---|---|
| SDS-PAGE | Purity validation | |
| Western Blotting | Tag detection (His-tag) | |
| Functional Studies | Ligand-binding assays (hypothetical, based on family homology) |
Fpr-rs7’s sequence aligns most closely with Fpr-rs6 and Fpr-rs4, suggesting potential redundancy or specialized functions within the cluster .
Functional Ambiguity: Unlike Fpr1 or Fpr-rs1, Fpr-rs7 lacks validated ligands or knockout phenotypes.
Expression Variability: Recombinant Fpr-rs7 is produced in E. coli or mammalian cells, which may affect post-translational modifications .
Research Gaps: Limited studies on Fpr-rs7-specific signaling pathways or tissue expression profiles.
Future research should prioritize:
Ligand screening using recombinant Fpr-rs7.
RNA/protein expression profiling in olfactory or immune tissues.
STRING: 10090.ENSMUSP00000093297
Fpr-rs7 is a G protein-coupled receptor belonging to the formyl peptide receptor family in mice. Similar to other family members like Fpr2, it likely functions in the transduction of signals from various ligands to regulate inflammatory processes . The murine formyl peptide receptor family comprises multiple members with varying degrees of homology, with Fpr-rs7 sharing structural similarities to the well-studied Fpr2, though with distinct ligand specificity profiles.
Research with Fpr2 knockout models has demonstrated that these receptors play significant anti-inflammatory roles, serving various regulatory functions during host defense responses . By extrapolation, Fpr-rs7 likely contributes to similar physiological processes, though with potential functional specializations that remain to be fully characterized.
Fpr-rs7 shows a tissue-specific expression pattern that differs from other family members. While comprehensive expression data for Fpr-rs7 specifically is still emerging, research on related receptors like Fpr2 indicates expression primarily in immune cells such as neutrophils and macrophages. Methodologically, researchers can determine Fpr-rs7 expression using:
Quantitative RT-PCR with receptor-specific primers
In situ hybridization for tissue localization
Immunohistochemistry with validated antibodies
Flow cytometry for cellular expression
Experimental validation should include appropriate controls, particularly given the sequence similarities among Fpr family members.
Based on studies of homologous receptors, Fpr-rs7 likely activates several intracellular signaling cascades following ligand binding. Studies with Fpr2 have shown that receptor activation leads to ERK phosphorylation induced by ligands such as annexin A1-derived peptide Ac2–26 and other receptor-specific compounds .
Methodological approaches to study Fpr-rs7 signaling should include:
Western blotting for phosphorylated signaling proteins (ERK, p38 MAPK)
Calcium flux assays to measure intracellular calcium mobilization
cAMP accumulation assays to assess G protein coupling
β-arrestin recruitment assays for receptor internalization studies
When designing experiments, researchers should consider using specific inhibitors to dissect the contributions of individual pathways to the observed cellular responses.
While specific data for Fpr-rs7 requires further investigation, research on Fpr2 provides valuable insights. Fpr2 demonstrates significant anti-inflammatory properties, with knockout mice showing increased cell adherence and emigration in the mesenteric microcirculation following ischemia-reperfusion injury . Additionally, the antimigratory effects of compounds such as lipoxin A4, annexin A1, and dexamethasone were substantially reduced in Fpr2-deficient mice .
For studying Fpr-rs7's role in neutrophil migration, researchers should consider:
Transwell migration assays with isolated neutrophils
In vivo neutrophil recruitment models (air pouch, peritonitis)
Intravital microscopy to visualize leukocyte-endothelial interactions
Flow cytometry analysis of adhesion molecule expression
Creating reliable Fpr-rs7 knockout models requires careful design and comprehensive validation. Based on approaches used for Fpr2 knockout mice, researchers should:
Employ gene targeting strategies that ensure complete deletion of functional receptor expression
Verify deletion through multiple methods:
Southern blot analysis to confirm gene targeting
PCR genotyping for routine screening
Functional validation through radioligand binding assays
Absence of receptor-mediated cellular responses
The development of Fpr2 knockout mice has provided valuable insights into anti-inflammatory functions, revealing that these mice exhibit exacerbated inflammation in various models and inability to resolve chronic pathology . Similar approaches for Fpr-rs7 would likely yield important functional data.
To characterize Fpr-rs7 ligand binding with precision:
Radioligand binding assays using cells expressing recombinant Fpr-rs7
Competition binding assays with potential ligands
Scatchard analysis to determine binding affinities
BRET/FRET-based binding assays for real-time binding kinetics
Research with Fpr2 has employed radioligand binding assays to confirm the functional absence of the receptor in knockout models . Similar methodologies can be adapted for Fpr-rs7, with appropriate controls to account for potential binding to other formyl peptide receptors.
Distinguishing Fpr-rs7-specific functions from those of related receptors requires strategic experimental design:
Use receptor-selective ligands where available
Employ siRNA or CRISPR-Cas9 for selective receptor knockdown
Utilize cells from knockout mice lacking specific receptor subtypes
Perform receptor reconstitution experiments in knockout backgrounds
Create chimeric receptors to identify structural determinants of specificity
Studies with Fpr2 knockout mice demonstrated that ERK phosphorylation triggered by serum amyloid A remained intact, while responses to the annexin A1-derived peptide Ac2–26 and other Fpr2-specific ligands were markedly attenuated . Similar strategies can help delineate Fpr-rs7's unique functional profile.
While direct evidence for Fpr-rs7 in chronic inflammation models is still emerging, insights from Fpr2 research are instructive. Fpr2 knockout mice exhibited heightened sensitivity to arthrogenic serum and complete inability to resolve this chronic pathology . This suggests anti-inflammatory and pro-resolving functions that may be shared by Fpr-rs7.
To study Fpr-rs7 in chronic inflammation:
Employ multiple disease models (arthritis, inflammatory bowel disease, etc.)
Assess both acute and chronic phases of inflammation
Measure resolution parameters (specialized pro-resolving mediators, clearance of apoptotic cells)
Compare phenotypes between wild-type and receptor-deficient mice
Appropriate statistical analysis is crucial for rigorous interpretation of Fpr-rs7 research:
For comparing wild-type and knockout responses, use appropriate statistical tests based on data distribution:
t-tests for normally distributed data
Mann-Whitney U test for non-parametric comparisons
ANOVA with appropriate post-hoc tests for multiple group comparisons
For dose-response experiments:
Use non-linear regression to calculate EC50/IC50 values
Compare curve parameters statistically
For time-course experiments:
Consider area under curve (AUC) analysis
Apply repeated measures ANOVA where appropriate
The following F-table provides critical values for testing significance in ANOVA analyses commonly used in receptor studies:
| DF2 \ DF1 | 1 | 2 | 3 | 4 | 5 |
|---|---|---|---|---|---|
| 5 | 6.61 | 5.79 | 5.41 | 5.19 | 5.05 |
| 10 | 4.96 | 4.10 | 3.71 | 3.48 | 3.33 |
| 15 | 4.54 | 3.68 | 3.29 | 3.06 | 2.90 |
| 20 | 4.35 | 3.49 | 3.10 | 2.87 | 2.71 |
| 30 | 4.17 | 3.32 | 2.92 | 2.69 | 2.53 |
Results are significant when the F-value exceeds the critical value in the table .
When confronted with conflicting results:
Carefully evaluate experimental conditions:
Cell types and sources
Ligand concentrations and purity
Assay conditions and readouts
Mouse strain differences
Consider receptor expression levels:
Endogenous vs. overexpression systems
Compensatory changes in knockout models
Examine potential context-dependent functions:
Inflammatory state of the system
Presence of co-receptors or regulatory proteins
Influence of the microenvironment
Perform rigorous validation experiments:
Independent replication with varied approaches
Use of multiple ligands and readouts
Genetic and pharmacological approaches
Translating mouse Fpr-rs7 research to human applications requires careful consideration of species differences:
Conduct comparative sequence and structure analysis between murine Fpr-rs7 and human FPR family members
Perform parallel functional studies in mouse and human cells
Validate findings in humanized mouse models where appropriate
Correlate receptor expression patterns between species
Research on Fpr2 has supported the development of receptor agonists as potential anti-inflammatory therapeutics . Similar translational approaches may be applicable to Fpr-rs7-targeted interventions, pending further characterization of its specific functions.
Understanding Fpr-rs7 biology may contribute to novel therapeutic strategies:
Development of selective Fpr-rs7 modulators (agonists/antagonists)
Identification of endogenous ligands with therapeutic potential
Targeting of Fpr-rs7-dependent pathways in inflammatory conditions
Biomarker development based on receptor expression or activity
Research with Fpr2 has demonstrated its anti-inflammatory role and importance in resolving chronic inflammation , suggesting that targeting these receptors may offer therapeutic benefits in inflammatory diseases. As Fpr-rs7 functions become better characterized, similar applications may emerge.